J. Hows

发表

Use of a hypervariable minisatellite DNA probe (33.15) for evaluating engraftment two or more years after bone marrow transplantation for aplastic anaemia

A. Jeffreys, J. Goldman, J. Weitzel, 1988, British journal of haematology.

Bone marrow-derived mesenchymal stem cells

J. Hows, K. Kemp, C. Donaldson, 2005, Leukemia & lymphoma.

Adult bone marrow is a rich source of human mesenchymal ‘stem’ cells but umbilical cord and mobilized adult blood are not

J. Hows, C. Donaldson, S. Wexler, 2003, British journal of haematology.

Ciprofloxacin resistant Serratia marcescens endocarditis as a complication of non-Hodgkin's lymphoma.

J. Hows, A. Nicol, A. Macgowan, 1994, The Journal of infection.

Identification of the CD33‐related Siglec receptor, Siglec‐5 (CD170), as a useful marker in both normal myelopoiesis and acute myeloid leukaemias

P. Virgo, C. Erickson-Miller, J. Hows, 2003, British journal of haematology.

Dyskeratosis congenita fibroblasts are abnormal and have unbalanced chromosomal rearrangements.

L. Luzzatto, D. Oscier, I. Dokal, 1992, Blood.

Evaluation of the manual hexadimethrine bromide (Polybrene) technique in the investigation of autoimmune hemolytic anemia

J. Hows, I. Owen, 1990, Transfusion.

Comparison of long-term outcomes after allogeneic hematopoietic stem cell transplantation from matched sibling and unrelated donors

J. Passweg, A. Tichelli, P. Ljungman, 2006, Bone Marrow Transplantation.

Allogeneic Bone Marrow Transplantation for Chronic Myeloid Leukemia Using Sibling and Volunteer Unrelated Donors: A Comparison of Complications in the First 2 Years

A. Barrett, J. Goldman, A. Schwarer, 1993, Annals of Internal Medicine.

Adult stem cell therapy beyond haemopoietic stem cell transplantation? An update.

J. Hows, 2005, Transplant immunology.

Survival after antilymphocyte globulin therapy for aplastic anemia depends on disease severity

E. Gordon-Smith, J. Hows, K. Bryett, 1987 .

Histocompatible unrelated volunteer donors compared with HLA nonidentical family donors in marrow transplantation for aplastic anemia and leukemia.

Apperley, L. J., J. Goldman, 1986, Blood.

CYTOTOXIC T LYMPHOCYTE PRECURSOR FREQUENCY ANALYSES IN BONE MARROW TRANSPLANTATION WITH VOLUNTEER UNRELATED DONORS VALUE IN DONOR SELECTION

J. Goldman, Richard Szydlo, J. Hows, 1995, Transplantation.

MARROW TRANSPLANTATION FOR PATIENTS IN THE CHRONIC PHASE OF CHRONIC GRANULOCYTIC LEUKAEMIA

D. Catovsky, J. Goldman, J. R. Batchelor, 1982, The Lancet.

Incidence and specificity of HLA antibodies in multitransfused patients with acquired aplastic anemia

J. Hows, M. Younie, B. Bradley, 2004, Transfusion.

Viral (polyomavirus) cystitis heralding cytomegalovirus infection

A. Barrett, J. Goldman, D. Marks, 1992, The Lancet.

Growth of human umbilical-cord blood in longterm haemopoietic cultures

T. Luft, T. Dexter, J. Hows, 1992, The Lancet.

The CD34+CD38neg population is significantly increased in haemopoietic cell expansion cultures in serum-free compared to serum-replete conditions: dissociation of phenotype and function

J. Hows, C. Donaldson, P. Denning-Kendall, 2001, Bone Marrow Transplantation.

The CD34(+)CD38(neg) population is significantly increased in haemopoietic cell expansion cultures in serum-free compared to serum-replete conditions: dissociation of phenotype and function.

J. Hows, C. Donaldson, P. Denning-Kendall, 2001, Bone marrow transplantation.

Cobblestone Area‐Forming Cells in Human Cord Blood Are Heterogeneous and Differ from Long‐Term Culture‐Initiating Cells

J. Hows, P. Denning-Kendall, B. Bradley, 2003, Stem cells.

Hemopoietic Stem Cells as Targets for Genetic Manipulation

J. Hows, N. Testa, E. A. Wynter, 1999 .

Prediction of graft versus host disease by frequency analysis of cytotoxic T cells after unrelated donor bone marrow transplantation.

S. Mackinnon, J. Goldman, T. Hughes, 1989, Transplantation.

Frequency analysis of cytotoxic T lymphocyte precursors--possible relevance to HLA-matched unrelated donor bone marrow transplantation.

M. Ritter, J. Hows, E. Kaminski, 1988, Bone marrow transplantation.

Progenitor cell expansion The CD34 + CD38 neg population is significantly increased in haemopoietic cell expansion cultures in serum-free compared to serum-replete conditions: dissociation of phenotype and function

J. Hows, C. Donaldson, P. Denning-Kendall, 2001 .

Subacute encephalopathy associated with human immunodeficiency virus in haemophilia A.

S. Durrant, J. Hows, A. Rahemtulla, 1986, British medical journal.

Bone marrow transplants from mismatched related and unrelated donors for severe aplastic anemia

H. Schrezenmeier, G. Socié, E. Gluckman, 2006, Bone Marrow Transplantation.

Bone marrow transplantation for patients with chronic myeloid leukaemia: T-cell depletion with Campath-1 reduces the incidence of graft-versus-host disease but may increase the risk of leukaemic relapse.

R. Marcus, H. Waldmann, J. Apperley, 1986, Bone marrow transplantation.

Effectiveness of Immunosuppressive Therapy in Older Patients with Aplastic Anemia

A. Gratwohl, J. Passweg, A. Tichelli, 1999, Annals of Internal Medicine.

Bone marrow transplantation for chronic myeloid leukemia: the use of histocompatible unrelated volunteer donors.

S. Mackinnon, D. Catovsky, J. Goldman, 1990, Experimental hematology.

Therapy for chronic myelogenous leukemia with unrelated donor bone marrow transplantation: results in 102 cases.

P. Beatty, J. Hows, P. Mcglave, 1990, Blood.

P. Beatty, P. Mcglave, J. Hows, 1989, Bone marrow transplantation.

Survival after antilymphocyte globulin therapy for aplastic anemia depends on disease severity.

E. Gordon-Smith, J. Hows, K. Bryett, 1987, Blood.

Autoimmune hemolytic anemia associated with anti‐Sc1

J. Poole, J. Hows, M. E. Reid, 1992, Transfusion.

Treatment of acquired severe aplastic anemia: bone marrow transplantation compared with immunosuppressive therapy--The European Group for Blood and Marrow Transplantation experience.

R. Brand, J. Passweg, A. Tichelli, 2000, Seminars in hematology.

Abnormal cytogenetic clones in patients with aplastic anaemia: response to immunosuppressive therapy

C. Harrison, E. Gordon-Smith, J. Hows, 1999, British journal of haematology.

Long‐term follow‐up of severe aplastic anaemia patients treated with antithymocyte globulin

A. Bacigalupo, A. Brand, N. Frickhofen, 1989 .

CONGENITAL MYELODYSPLASIA: A NEWLY DESCRIBED DISEASE ENTITY?

M. McMullin, J. Hows, M. Chisholm, 1991, British journal of haematology.

Prospective randomized multicenter study comparing cyclosporin alone versus the combination of antithymocyte globulin and cyclosporin for treatment of patients with nonsevere aplastic anemia: a report from the European Blood and Marrow Transplant (EBMT) Severe Aplastic Anaemia Working Party.

J. Passweg, A. Tichelli, P. Ljungman, 1999, Blood.

Relapse of aplastic anaemia after immunosuppressive treatment: a report from the European Bone Marrow Transplantation Group SAA Working Party

P. Ljungman, H. Schrezenmeier, E. Gluckman, 1993, British journal of haematology.

Quantitation of cyclosporine-sensitive and -resistant allospecific cytotoxic cells at birth

J. Hows, I. Dittmer, C. Truman, 2000 .

The role of occupational and environmental exposures in the aetiology of acquired severe aplastic anaemia: a case control investigation

C. Chilvers, M. Grainge, E. Gordon-Smith, 2003, British journal of haematology.

Relapse into blast crisis following bone marrow transplantation for chronic phase chronic myeloid leukaemia: a report of five cases

D. Swirsky, D. Marks, J. M. Goldman, 1992, British journal of haematology.

Guidelines for the collection, processing and storage of human bone marrow and peripheral stem cells for transplantation

J. Duguid, S. Knowles, J. Wood, 1994, Transfusion medicine.

Paediatric bone marrow transplantation using donors other than HLA genotypically identical siblings.

S. Mackinnon, J. Hows, J. Goldman, 1991, Archives of disease in childhood.

J. Passweg, A. Tichelli, P. Ljungman, 1999, Blood.

Erythroid HLA Class I Expression in 300 Patients with Haematological, Renal and Rheumatological Disorders

M. Ritter, C. Pusey, M. Walport, 1990, Vox sanguinis.

Lymphocytes from multi‐transfused patients exhibit cytotoxicity against autologous cells

J. Goldman, J. Hows, J. Batchelor, 1992, British journal of haematology.

1 Alkylating chemotherapeutic agents cyclophosphamide and melphalan cause functional injury to human bone marrow-derived mesenchymal stem cells

Kelly Sanders, J. Hows, Dr Kevin Kemp, 2016 .

CORD BLOOD TRANSPLANTATION: A PRACTICAL OPTION?

J. Hows, B. Bradley, A. Nicol, 1994, British journal of haematology.

Optimal cryopreservation of human umbilical cord blood.

J. Hows, W. Armitage, C. Donaldson, 1996, Bone marrow transplantation.

Alkylating chemotherapeutic agents cyclophosphamide and melphalan cause functional injury to human bone marrow-derived mesenchymal stem cells

Kelly Sanders, J. Hows, K. Kemp, 2011, Annals of Hematology.

Chemotherapy-induced mesenchymal stem cell damage in patients with hematological malignancy

E. Mallam, J. Hows, K. Kemp, 2010, Annals of Hematology.

Endothelial cell precursors are normal components of human umbilical cord blood

J. Sweetenham, J. Hows, M. Nieda, 1997, British journal of haematology.

Long-term follow-up of severe aplastic anaemia patients treated with antithymocyte globulin. Severe Aplastic Anaemia Working Party of the European Cooperative Group for Bone Marrow Transplantation (EBMT).

A. Bacigalupo, A. Brand, N. Frickhofen, 1989, British journal of haematology.

Haemopoietic growth factors in aplastic anaemia: a cautionary note

A. Tichelli, P. Ljungman, A. Bacigalupo, 1994, The Lancet.

Influence of Donor/Recipient Sex Matching on Outcome of Allogeneic Hematopoietic Stem Cell Transplantation for Aplastic Anemia

A. Gratwohl, J. Passweg, A. Tichelli, 2006, Transplantation.

J. Hows, B. Bradley, 1990, British journal of haematology.

Bone marrow transplantation for chronic myeloid leukemia with volunteer unrelated donors using ex vivo or in vivo T-cell depletion: major prognostic impact of HLA class I identity between donor and recipient.

J. Goldman, H. Waldmann, F. van Rhee, 1995, Blood.

The pharmacokinetics of once daily gentamicin in neutropenic adults with haematological malignancy.

A. MacGowan, N. Brown, L. White, 1994, The Journal of antimicrobial chemotherapy.

Induction of in vitro graft-versus-leukemia activity following bone marrow transplantation for chronic myeloid leukemia.

S. Mackinnon, J. Goldman, J. Hows, 1990, Blood.

Mechanisms of graft failure after human marrow transplantation: a review.

J. Hows, 1991, Immunology letters.

Current Results of Bone Marrow Transplantation in Patients with Acquired Severe Aplastic Anemia

J. Passweg, A. Tichelli, P. Ljungman, 2000, Acta Haematologica.

Bone marrow transplantation for severe aplastic anemia: influence of conditioning and graft-versus-host disease prophylaxis regimens on outcome.

A. Rimm, M. Horowitz, R. Gale, 1992, Blood.

Spontaneous graft-versus-host disease following autologous peripheral blood progenitor cell transplantation in chronic myeloid leukaemia.

R. Howell, P. Burton, J. Hows, 1996, Bone marrow transplantation.

Clonal hematopoiesis as defined by polymorphic X-linked loci occurs infrequently in aplastic anemia.

A. Schulz, C. Bartram, T. Dexter, 1995, Blood.

Slow evolution of chronic myeloid leukaemia relapsing after BMT with T‐cell depleted donor marrow

S. Mackinnon, F. Rassool, J. M. Goldman, 1989, British journal of haematology.

Airways obstruction associated with graft versus host disease after bone marrow transplantation.

D. Catovsky, J. Goldman, P. Nunn, 1984, Thorax.

MEGA‐DOSE METHYLPREDNISOLONE FOR APLASTIC ANAEMIA

J. Hows, S. Özsoylu, 1991 .

Serial chimerism analyses indicate that mixed haemopoietic chimerism influences the probability of graft rejection and disease recurrence following allogeneic stem cell transplantation (SCT) for severe aplastic anaemia (SAA): indication for routine assessment of chimerism post SCT for SAA

J. Passweg, A. Tichelli, P. Ljungman, 2009, British journal of haematology.

Bone marrow transplantation for severe aplastic anemia: influence of conditioning and graft-versus-host disease prophylaxis regimens on outcome.

A. Rimm, M. Horowitz, R. Gale, 1992, Blood.

Pretransfused patients with severe aplastic anaemia exhibit high numbers of cytotoxic T lymphocyte precursors probably directed at non‐HLA antigens

J. Goldman, J. Hows, E. Kaminski, 1990, British journal of haematology.

Treatment of Severe Aplastic Anemia (SAA) with Bone Marrow Transplantation (BMT) or Immunosuppression: A Report of the EBMT SAA Working Party

A. Grañena, E. Smith, E. Gluckman, 1990 .

Bone marrow transplantation (BMT) versus immunosuppression for the treatment of severe aplastic anaemia (SAA): a report of the EBMT * SAA Working Party

E. Gluckman, A. Bacigalupo, N. Frickhofen, 1988, British journal of haematology.

Cyclosporine and graft failure following bone marrow transplantation for severe aplastic anaemia

E. Gordon-Smith, J. Hows, S. P almer, 1985, British journal of haematology.

Human immunodeficiency virus and blood transfusion

J. Whitwam, J. Hows, V. Chowdhury, 1988 .

1994 Consensus Conference on Acute GVHD Grading.

E D Thomas, D. Weisdorf, E. Thomas, 1995, Bone marrow transplantation.

Major surgery in von Willebrand's disease.

D. Royston, K. Taylor, I. Dokal, 1989, Clinical and laboratory haematology.

"Stem cell" origin of the hematopoietic defect in dyskeratosis congenita.

T. Dexter, D. Oscier, J. Hows, 1992, Blood.

Interleukin-10 and tumor necrosis factor alpha region haplotypes predict transplant-related mortality after unrelated donor stem cell transplantation.

J. Bidwell, S. Davies, T. DeFor, 2004, Blood.

Bone marrow transplantation for severe aplastic anemia: has outcome improved?

J. Klein, M. Horowitz, R. Gale, 1997, Blood.

Malignant tumors occurring after treatment of aplastic anemia. European Bone Marrow Transplantation-Severe Aplastic Anaemia Working Party.

A. Tichelli, P. Ljungman, M. Henry-Amar, 1993, The New England journal of medicine.

Bone marrow transplantation for severe aplastic anaemia using cyclosporin: long-term follow-up.

D. Swirsky, J. Hows, J. Marsh, 1989, Bone marrow transplantation.

Bone marrow transplantation for severe aplastic anemia from donors other than HLA identical siblings: a report of the BMT Working Party.

E. Gluckman, A. Bacigalupo, E. Gordon-Smith, 1988, Bone marrow transplantation.

Immunosuppression with Cyclosporin A in Allogeneic Bone Marrow Transplantation for Severe Aplastic Anaemia: Preliminary Studies

E. Gordon-Smith, J. Hows, R. Harris, 1981, British journal of haematology.

Treatment with marrow transplantation or immunosuppression of childhood acquired severe aplastic anemia: a report from the EBMT SAA Working Party.

E. Gluckman, A. Bacigalupo, J. Vossen, 1990, Bone marrow transplantation.

Oral squamous cell carcinoma after allogeneic bone marrow transplantation for Fanconi anaemia

P. Burton, D. Swirsky, J. Hows, 1997, British journal of haematology.

Effect of tolerance to noninherited maternal antigens on the occurrence of graft-versus-host disease after bone marrow transplantation from a parent or an HLA-haploidentical sibling.

F. Claas, R. Gale, O. Ringdén, 2002, Blood.

Bone marrow transplantation for chronic myeloid leukaemia in first chronic phase: importance of a graft‐versus‐leukaemia effect

W. Gregory, F. Mandelli, G. Papa, 1988, British journal of haematology.

Bone marrow transplantation for patients with chronic myeloid leukemia.

R. Marcus, D. Catovsky, J. Goldman, 1986, The New England journal of medicine.

Outcome of Pregnancy and Disease Course among Women with Aplastic Anemia Treated with Immunosuppression

J. Passweg, A. Tichelli, A. Symeonidis, 2002, Annals of Internal Medicine.

Diagnosis of sickle-cell disease with a universal heteroduplex generator

G. Standen, J. Hows, N. Wood, 1993, The Lancet.

Cryopreserved Human Bone Marrow Stroma is Fully Functional In vitro

J. Hows, M. Nieda, C. Truman, 1996, British journal of haematology.

Chromosome translocations and covert leukemic clones are generated during normal fetal development

M. Greaves, S. Colman, L. Healy, 2002, Proceedings of the National Academy of Sciences of the United States of America.

Immunological reconstitution after bone marrow transplant with Campath-1 treated bone marrow.

D. Catovsky, J. Goldman, J. Apperley, 1987, Clinical and experimental immunology.

The hematopoietic defect in aplastic anemia assessed by long-term marrow culture.

J. Chang, T. Dexter, J. Hows, 1990, Blood.

Prospective evaluation of unrelated donor bone marrow transplantation. The International Marrow Unrelated Search and Transplant (IMUST) Study.

S. Gore, E. Gluckman, J. Hows, 1993, Bone marrow transplantation.

Donor-derived red blood cell antibodies and immune hemolysis after allogeneic bone marrow transplantation

E. Gordon-Smith, J. Hows, I. Sniecinski, 1986 .

Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings.

J P Klein, J J van Rood, F H Bach, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Late onset immune pancytopenia following bone marrow transplantation

M. McMullin, P. Mahendra, L. Tyfield, 1991, British journal of haematology.

Bone marrow transplantation for Fanconi's anaemia: the Hammersmith experience 1977-89.

D. Swirsky, E. Gordon-Smith, J. Hows, 1989, Bone marrow transplantation.

The hematopoietic defect in aplastic anemia assessed by long-term marrow culture

Jenny C. Chang, T. Dexter, J. Hows, 1990 .

Comparison of purity and enrichment of CD34+ cells from bone marrow, umbilical cord and peripheral blood (primed for apheresis) using five separation systems

T. Luft, J. Hows, N. Testa, 1995, Stem cells.

Graft rejection and second bone marrow transplants for acquired aplastic anaemia: a report from the Aplastic Anaemia Working Party of the European Bone Marrow Transplant Group.

P. Ljungman, E. Gluckman, A. Bacigalupo, 1994, Bone marrow transplantation.

Bone marrow transplants using volunteer donors--recommendations and requirements for a standardized practice throughout the world. The Executive Committee of the World Marrow Donor Association.

A. Gratwohl, J. Goldman, J. Hansen, 1992, Bone marrow transplantation.

Bone-marrow transplantation for severe aplastic anaemia using histocompatible unrelated volunteer donors.

E. Gordon-Smith, J. Hows, J. Batchelor, 1982, British medical journal.

Late onset bone marrow failure associated with proximal fusion of radius and ulna: a new syndrome

P. Ganly, I. Dokal, J. Hows, 1989, British journal of haematology.

SEVERE APLASTIC ANAEMIA: THE PATIENT WITHOUT A HLA‐IDENTICAL SIBLING

J. Hows, 1991, British journal of haematology.

Donor-derived red blood cell antibodies and immune hemolysis after allogeneic bone marrow transplantation.

R. Krance, E. Gordon-Smith, J. Hows, 1986, Blood.

Optimal processing of human umbilical cord blood for clinical banking.

J. Hows, C. Donaldson, P. Denning-Kendall, 1996, Experimental hematology.

HLA‐identical sibling donor bone marrow transplantation for chronic myeloid leukaemia in first chronic phase: influence of GVHD prophylaxis on outcome

A. Barrett, S. Mackinnon, J. Goldman, 1992, British journal of haematology.

Two distinct patterns of glycosylphosphatidylinositol (GPI) linked protein deficiency in the red cells of patients with paroxysmal nocturnal haemoglobinuria

Lucio Luzzatto, L. Luzzatto, Peter Hillmen, 1992, British journal of haematology.

Treatment of aplastic anaemia (AA) with antilymphocyte globulin (ALG) and methylprednisolone (MPred) with or without androgens: a randomized trial from the EBMT SAA working party

E. Smith, A. Bosi, A. Goldstone, 1993, British journal of haematology.

Bone marrow transplantation (BMT) in children with severe aplastic anemia (SAA) from donors other than HLA identical siblings. EBMT Working Party on Severe Aplastic Anemia.

E. Gluckman, J. Vossen, S. McCann, 1991, Bone marrow transplantation.

Peripheral blood progenitor cell transplantation: where do we stand? Chairman's Summary of the European School of Oncology Task Force meeting Peripheral Blood progenitor cell's held September 29-30, 1995.

D. Khayat, W. Brugger, D. Linch, 1996, Annals of oncology : official journal of the European Society for Medical Oncology.

In vitro assessment of marrow ‘stem cell’and stromal cell function in aplastic anaemia

J. Chang, T. Dexter, J. Hows, 1991, British journal of haematology.

Optimising a limiting dilution culture system for quantitating frequencies of alloreactive cytotoxic T lymphocyte precursors.

J. Goldman, J. Hows, E. Kaminski, 1991, Cellular immunology.

In vitro methods and selection of HLA-matched unrelated donors for bone marrow transplantation.

J. R. Batchelor, J. Bridge, J. Hows, 1991, Transplantation proceedings.

S. Mackinnon, N. Cross, H. Waldmann, 1993, Bone marrow transplantation.

Cytokine Expansion Culture of Cord Blood CD34+ Cells Induces Marked and Sustained Changes in Adhesion Receptor and CXCR4 Expressions

J. Hows, P. Denning-Kendall, B. Bradley, 2003, Stem cells.

Reduced incidence of GVHD in recipients of t-cell depleted marrow

J. Goldman, H. Waldmann, J. Apperley, 1986 .

Aplastic anaemia in association with coeliac disease: a series of three cases

J. Hows, J. Marsh, E. Grey-Davies, 2008, British journal of haematology.

S. Gore, J. Goldman, H. Prentice, 1990, Transplantation.

Direct comparison by limiting dilution analysis of long-term culture-initiating cells in human bone marrow, umbilical cord blood, and blood stem cells.

T. Luft, T. Dexter, R. Henschler, 1994, Blood.

A prospective study of factors determining the outcome of unrelated marrow donor searches: report from the International Marrow Unrelated Search and Transplant Study Working Group on behalf of collaborating centres.

S. Gore, J. Hows, B. Bradley, 1994, Bone marrow transplantation.

Recurrent graft failure following syngeneic bone marrow transplantation for aplastic anaemia.

M. Laffan, E. Gordon-Smith, J. Hows, 1989, Bone marrow transplantation.

Seroconversion of human T cell lymphotrophic virus III (HTLV-III) in patients with haemophilia: a longitudinal study.

R. Weiss, L. Luzzatto, A. Chu, 1985, British medical journal.

J. Goldman, J. Hows, P. Brookes, 1989, Transplantation proceedings.

Engraftment and Immune Reconstitution

A. Tichelli, G. Socié, A. Bacigalupo, 2002, Bone Marrow Transplantation.

Origin and function of adherent lymphokine activated killer cells in patients with chronic myeloid leukaemia who relapse following bone marrow transplantation

S. Mackinnon, J. Goldman, A. Chase, 1991, British journal of haematology.

Induction of a syngeneic graft-versus-leukemia effect following bone marrow transplantation for chronic myeloid leukemia.

S. Mackinnon, J. Goldman, J. Hows, 1990, Leukemia.

C. Anasetti, E. Gluckman, B. Camitta, 1992, Bone marrow transplantation.

Consensus Conference on the Treatment of Aplastic Anemia.

M. Tomonaga, H. Mizoguchi, S. Kojima, 2000, International journal of hematology.

Late Mortality Following Allogeneic Stem Cell Transplantation Is Closely Associated with Chronic Graft Versus Host Disease but Not with Donor Type.

J. Passweg, A. Tichelli, G. Socié, 2004 .

HLA-DR and DQ matching by DNA restriction fragment length polymorphism methods and the outcome of mixed lymphocyte reaction tests in unrelated bone marrow donor searches. The IMUST Study.

J. Bidwell, J. Hows, P. Brookes, 1992, Bone marrow transplantation.

Alloreactive cytotoxic T-cell frequency analysis and HLA matching for bone marrow transplants from HLA matched unrelated donors.

S. Mackinnon, J. Goldman, T. Hughes, 1989, Transplantation proceedings.

Obstetric factors influencing cord blood collections

J. Hows, W. Armitage, C. Donaldson, 1998 .

S. Gore, J. Hows, B. Bradley, 1993, Bone marrow transplantation.

Cytotoxic T lymphocyte precursor (CTL-p) frequency analysis in unrelated donor bone marrow transplantation: two case studies.

J. Goldman, J. Bridge, J. Hows, 1991, Bone marrow transplantation.

congenita "Stem cell" origin of the hematopoietic defect in dyskeratosis

D. Oscier, J. Hows, J. Marsh, 2011 .

Autologous cord blood transplantation. A procedure with potential beyond bone marrow replacement?

A. Gratwohl, H. Have, J. Hows, 2000, Bone Marrow Transplantation.

J. Klein, K. Sullivan, R. Gale, 2007, British journal of haematology.

Extent of transplantation in Britain is overrepresented

J. Hows, M. G. Rainey, 1995, BMJ.

Second transplants for patients with chronic myeloid leukaemia in relapse after original transplant with T‐depleted donor marrow: feasibility of using busulphan alone for re‐conditioning

J. M. Goldman, J. Hows, I. Franklin, 1992, British journal of haematology.

Status of umbilical cord blood transplantation in the year 2001

J. Hows, J. Hows, 2001, Journal of clinical pathology.

Haematological reconstitution and severity of graft‐versus‐host disease after bone marrow transplantation for chronic granulocytic leukaemia: the influence of previous splenectomy

D. Catovsky, D. Galton, J. Goldman, 1984, British journal of haematology.

The Association of Eosinophilia with Lymphoblastic Leukaemia or Lymphoma: a Study of Seven Patients

D. Catovsky, D. Galton, E. Morra, 1980, British journal of haematology.

Malignancy Presenting as Peripheral Venous Gangrene

G. Poston, T. Littlewood, J. Hows, 1988, Journal of the Royal Society of Medicine.

Donor search or autografting in patients with acute leukaemia who lack an HLA-identical sibling? A matched-pair analysis

M. Labopin, O. Ringdén, L. Fouillard, 1997, Bone Marrow Transplantation.

Umbilical cord blood for transplantation SIR,—Professor Dunn (Aug 1, p 309) refers to our work (July 11,

E. Gluckman, J. Hows, D. Thierry, 1992, The Lancet.

Bone Marrow Transplantation for Patients in the Chronic Phase of Chronic Granulocytic Leukaemia: Apparent Low Incidence of Relapse within the First Two Years Post-BMT

R. Marcus, D. Catovsky, J. Goldman, 1985 .

Avascular necrosis after treatment of aplastic anaemia with antilymphocyte globulin and high‐dose methylprednisolone

E. Gordon-Smith, J. Hows, J. Hows, 1993, British journal of haematology.

Human cord blood: a source of transplantable stem cells?

T. Luft, T. Dexter, J. Hows, 1992, Bone Marrow Transplantation.

Effectiveness of immunosuppressive therapy in older patients with aplastic anemia. European Group for Blood and Marrow Transplantation Severe Aplastic Anaemia Working Party.

A. Tichelli, P. Ljungman, M. Henry-Amar, 1999, Annals of internal medicine.